Login to Your Account

ASCO 2014

Clinical trial transparency: Hopes, but first, hard work

By Anette Breindl
Science Editor

Monday, June 9, 2014

CHICAGO – To the typical attendee of the American Society of Clinical Oncology (ASCO) annual meeting last week, a shortage of clinical data would not appear to be an obvious or pressing problem. Attending the meeting usually means deciding, at any given moment, which two or three interesting presentations to forego for an even more interesting presentation.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription